New cancer drug combo enters human testing for Tough-to-Treat tumors
Disease control
Ongoing
This early-stage trial is testing a new drug called HCB101 when given alongside other approved cancer treatments. It aims to find a safe and effective dose and see if the combinations can help control advanced solid tumors, including specific types of stomach, breast, and lung ca…
Phase: PHASE1, PHASE2 • Sponsor: FBD Biologics Limited • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC